San Diego, CA (PRWEB) May 13, 2014
AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for dietary supplements.
As the FDA announced on May 6, African Black Ant, Black Ant and Mojo Risen, by Eugene Oregon Inc., are recalled because they were found to contain undeclared sildenafil and tadalafil.
These ingredients, FDA-approved to treat erectile dysfunction, can pose a threat to consumers if they interact with nitrates found in some prescription drugs (for the treatment of heart disease, high cholesterol, high blood pressure, and diabetes) leading to decreased blood pressure. Moreover, they can cause flushing and headaches.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning dietary supplements and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”
As the FDA recommends “Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these products.” And the Agency adds “Consumers that possess these products should stop using them immediately and can return the products to Eugene Oregon, Inc.”
AttorneyOne.com has further information on dietary supplements at the website including latest major drug and medical products law news.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11843276.htm